(Q24805292)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=317309

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=317309

Adverse Drug Events in Ambulatory Care

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=317309

The clinical and economic impact of pharmaceutical care in end-stage renal disease patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=317309

Pharmacist participation on physician rounds and adverse drug events in the intensive care unit

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=317309

Chronic hemodialysis patients. Part II: Reducing drug-related problems through application of the focused drug therapy review program

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=317309

Chronic hemodialysis patients. Part I: Characterization and drug-related problems

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=317309

Opportunities and responsibilities in pharmaceutical care

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=317309

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=317309

Evaluation of drug-related problems in an outpatient hemodialysis unit and the impact of a clinical pharmacist.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=317309

Factors associated with medication-related problems in ambulatory hemodialysis patients.

28 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2369-4-10

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=317309

Comparing medication use in two hemodialysis units against national dialysis databases

28 November 2018

1 reference

12 December 2020

Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study

1 reference

12 December 2020

1 reference

12 December 2020

Role-effectiveness of the pharmacist in the treatment of hemodialysis patients

1 reference

12 December 2020

Effectiveness of clinical pharmacist interventions in a hemodialysis unit

1 reference

12 December 2020

Drug-related hospital admissions

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2369-4-10

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4662608

Dimensions Publication ID

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2369-4-10

release_ieegce3zmzfjxkhsa3ja6zrrny

9 September 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ieegce3zmzfjxkhsa3ja6zrrny

24 November 2022

mapped directly with Wikidata item

OpenCitations bibliographic resource ID

4662608

1 reference